FDA NDC Directory · JSON-LD · Markdown

PADCEV EJFV

NDC 51144-030 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameENFORTUMAB VEDOTIN
Labeler / ManufacturerSEAGEN INC.
Marketing categoryBiologic License Application · App BLA761137
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsENFORTUMAB VEDOTIN (30 mg/3mL)
Marketing started20191218
Package count1

External sources

Source: openFDA. Public-domain (CC0).